Pure Global AI
Disease / condition

type 2 diabetes clinical trials

Free access to 346 studies10+ countriesUpdated daily44 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
346
Total trials
10+
Countries
10+
Sponsors
44
Recruiting
By phase
N/A234
Not Applicable61
Phase 438
Phase 16
Early Phase 14
By status
Completed189
Recruiting44
Not yet recruit...43
Terminated25
Recruitment Com...19
Top countries
Japan218
China66
Australia9
South Korea3
Netherlands3
Top sponsors
Inuyama Chuo Gener...20
Juntendo Universit...8
Novo Nordisk Pharm...7
Shiraiwa Medical C...5
Novo Nordisk A/S5
Recent trials
Latest clinical trials for type 2 diabetes
Untitled Trial
Showa University Hospital
jRCT1031230368Not yet recr...
Untitled Trial
Novo Nordisk Pharma Ltd.
jRCT2071230015Recruitment ...
Effects of Participatory Exercise Education Interventions in Diabetes Population Education on Exercise Self-Efficacy in Patients
TMG Asaka Medical Center Depar... · Japan
UMIN000050994Recruiting
Effects of extended time between lunch and dinner on postprandial and 24-hour blood glucose changes
University of Shizuoka · Japan
UMIN000050756Completed
Untitled Trial
Graduate School of Medicine Ky...
jRCT1050220190Not yet recr...
Changes in Rectus Femoris Brightness in Patients with Type 2 Diabetes Comparison before and 2 weeks after the start of exercise therapy in educational inpatients and outpatients
Obata Clinic · Japan
UMIN000050549Not yet recr...
AI Hospital program study based upon a research about retention rate of the diabetes diagnostic support service system and effectiveness and acceptability of the applications
Hatori Clinic Medical Corporat... · Japan
UMIN000049633Completed
The therapeutic effect of oral Semaglutide in older patients with type 2 diabetes mellitus
Hokkaido University Graduate S... · Japan
UMIN000048782Recruitment ...
Effect of tofogliflozin on glycemic fluctuation in patients with type 2 diabetes with non-alcoholic fatty liver disease (NAFLD)
Minami Osaka Hospital · Japan
UMIN000048523Not yet recr...
A prospective observational study assessing patient preference for oral vs. injectable semaglutide in Japanese patients with type 2 diabetes using insulin and GLP-1 receptor agonists
Kanto Rosai Hospital · Japan
UMIN000048407Completed
Renal protective effects of tofogliflozin and changes in clinical parameters affecting renal function in patients with type 2 diabetes
Department of Diabetes, Metabo... · Japan
UMIN000048277Completed
Untitled Trial
Shenzhen Hospital, Southern Me... · China
ChiCTR2200061520Not yet recr...
Phase
Not Applicable
Untitled Trial
Novo Nordisk Pharma Ltd. · Australia;Belgium;Bulgaria;China;Croatia;Finland;India;Italy;South Korea;Mexico;Norway;Poland;Portug
jRCT2031220146Recruitment ...
Effects of physical activity (radio calisthenics plus walking) on lowering blood glucose levels in Japanese patients with type 2 diabetes: an observational study
Tokyo Saiseikai Central Hospit... · Japan
UMIN000048094Completed
Phase
Not Applicable
Untitled Trial
Novo Nordisk Pharma Ltd. · Brazil;Canada;China;France;Greece;Hungary;Israel;Russia;Slovenia;Sweden;Switzerland;Taiwan,;United S
jRCT2051220044Recruitment ...
Effect of preoperative withdrawal of SGLT2 inhibitors on the development of perioperative euglycemic ketoacidosis in diabetic patients taking SGLT2 inhibitors
Department of Anesthesia, Tenr... · Japan
UMIN000048010Completed
Effects of Undaria pinnatifida (Wakame) on postprandial glycaemia
Fuji women's university · Japan
UMIN000047854Completed
Untitled Trial
Yonsei University Health Syste... · South Korea
KCT0007323Not yet recr...
Phase
Phase 3
Untitled Trial
jRCT1011220005Recruiting
Pilot study for the evaluation of glyceraldehyde as a source of advanced glycation end products
Graduate School of Medicine, K... · Japan
UMIN000047554Completed
About this profile

Access comprehensive clinical trial information for type 2 diabetes through Pure Global AI's free database. This collection includes 346 clinical trials across multiple phases including N/A, Not Applicable, Phase 4. Currently, 44 trials are actively recruiting participants.

Research for type 2 diabetes is being conducted in Japan, China, Australia and 7+ other countries. Leading sponsors include Inuyama Chuo General Hospital and Juntendo University Graduate School of Medicine. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 346 clinical trials studying type 2 diabetes, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Inuyama Chuo General Hospital, Juntendo University Graduate School of Medicine, Novo Nordisk Pharma Ltd., among others.